Botulinum Toxin Type A for Injection (HengLi®) in the Treatment of Trigeminal Neuralgia

Clinical trial NCT06410859 · UNKNOWN

Trial details

NCT number: NCT06410859
Sponsor: LKGS_277
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Trigeminal Neuralgia

Start date: 2024-04-25
Primary completion: 2026-06-30
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.